We are delighted to invite you the webinar 'Artificial Intelligence in Drug Development and Clinical Trials', with Dr. Olga Kubassova, hosted by International Pharmaceutical Federation (FIP) and chaired by Nikolina Biskic and Mathew Cherian. This webinar brings global stakeholders from drug development, operational and technology background who are interested in how disrupting technologies and novel concepts impact the way clinical trials are designed and executed. Dr Kubassova will speak about the fundamentals of a digital strategy for a biotech or pharma company, needed to leverage novel technologies within clinical trials. She will also discuss data-driven approach to drug development and cover how integrating AI into drug development process affects cost, speed and success of pharmaceutical drug development. You can bring these fundamentals with you into development of drugs in a particular indication or conducting a real-world evidence study. #clinicaltrials #drugdevelopment #innovation #AI
This content isn’t available here
Access this content and more in the LinkedIn app